Island Pharmaceuticals Limited (ASX:ILA)
Australia · Delayed Price · Currency is AUD 0.4170
-0.0030 (-0.71%)
Sep 22, 2026, 2:58 PM AEST
Island Pharmaceuticals Market Cap
Island Pharmaceuticals has a market cap or net worth of 124.29 million as of September 21, 2026. Its market cap has increased by 12.58% in one year.
Market Cap
124.29M
Enterprise Value
111.41M
Revenue
282.66K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.42
ChartMarket Cap Chart
Since April 13, 2021, Island Pharmaceuticals's market cap has increased from 42.51M to 124.29M, an increase of 192.38%. That is a compound annual growth rate of 21.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 124.29M | 7.43% |
| Dec 31, 2025 | 115.69M | 274.76% |
| Dec 31, 2024 | 30.87M | 299.86% |
| Dec 29, 2023 | 7.72M | -48.65% |
| Dec 28, 2022 | 15.03M | -27.45% |
| Dec 31, 2021 | 20.72M | -51.25% |
| Apr 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Orthocell | 187.91M |
| Nyrada | 180.38M |
| Dimerix | 147.10M |
| Paradigm Biopharmaceuticals | 146.80M |
| Recce Pharmaceuticals | 105.49M |
| Alterity Therapeutics | 99.32M |
| LTR Pharma | 82.71M |
| Avecho Biotechnology | 77.27M |